Acemannan accelerates cell proliferation and skin wound healing through AKT/mTOR signaling pathway

Journal of Dermatological Science

Volumn 79, Issue 2, 2014, Pages 101-109

  Xing, Wei ^a   Guo, Wei ^a   Zou, Cun Hua ^a,b   Fu, Ting Ting ^a,c   Li, Xiang Yun ^a   Zhu, Ming ^a   Qi, Jun Hua ^a,d   Song, Jiao ^a   Dong, Chen Hui ^a   Li, Zhuang ^a   Xiao, Yong ^a   Yuan, Pei Song ^a   Huang, Hong ^a   Xu, Xiang ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b Department of Otolaryngology   (China)

^c Women and Children Hospital ^*  (China)

^d HUBEI POLYTECHNIC UNIVERSITY   (China)

Author keywords

Acemannan; AKT; Cyclin D1; MTOR; Wound healing

Indexed keywords

ACEMANNAN; COLLAGEN; CYCLIN D1; CYCLIN DEPENDENT KINASE; INITIATION FACTOR 4E BINDING PROTEIN 1; INITIATION FACTOR 4F; KI 67 ANTIGEN; MAMMALIAN TARGET OF RAPAMYCIN; PROTEIN KINASE B; PROTEIN KINASE B INHIBITOR; RAPAMYCIN; S6 KINASE; CCND1 PROTEIN, MOUSE; IMMUNOLOGICAL ADJUVANT; MANNAN; MTOR PROTEIN, MOUSE; ONCOPROTEIN; TARGET OF RAPAMYCIN KINASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD4+ T LYMPHOCYTE; CELL CYCLE PROGRESSION; CELL CYCLE S PHASE; CELL PROLIFERATION; CONTROLLED STUDY; CYCLIN D1 GENE; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVATION; ENZYME ACTIVITY; FIBROBLAST; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN SECRETION; PROTEIN SYNTHESIS; SIGNAL TRANSDUCTION; SKIN INJURY; SKIN WOUND HEALING; TRANSLATION REGULATION; WOUND HEALING; ANIMAL; BAGG ALBINO MOUSE; CELL CULTURE; DRUG EFFECTS; METABOLISM;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; CELL PROLIFERATION; CELLS, CULTURED; CYCLIN D1; MALE; MANNANS; MICE; MICE, INBRED BALB C; MODELS, ANIMAL; ONCOGENE PROTEIN V-AKT; SIGNAL TRANSDUCTION; TOR SERINE-THREONINE KINASES; WOUND HEALING;

EID: 84955652885     PISSN: 09231811     EISSN: 1873569X     Source Type: Journal    
DOI: 10.1016/j.jdermsci.2015.03.016     Document Type: Article

References (32)

1. Gupta A., Upadhyay N.K., Sawhney R.C., Kumar R. A poly-herbal formulation accelerates normal and impaired diabetic wound healing. Wound Repair Regen 2008, 16:784-790.
2. Hamman J.H. Composition and applications of Aloe vera leaf gel. Molecules 2008, 13:1599-1616.
3. Maenthaisong R., Chaiyakunapruk N., Niruntraporn S., Kongkaew C. The efficacy of Aloe vera used for burn wound healing: a systematic review. Burns 2007, 33:713-718.
4. Atiba A., Nishimura M., Kakinuma S., Hiraoka T., Goryo M., Shimada Y., et al. Aloe vera oral administration accelerates acute radiation-delayed wound healing by stimulating transforming growth factor-beta and fibroblast growth factor production. Am J Surg 2011, 201:809-818.
5. Inpanya P., Faikrua A., Ounaroon A., Sittichokechaiwut A., Viyoch J. Effects of the blended fibroin/aloe gel film on wound healing in streptozotocin-induced diabetic rats. Biomed Mater 2012, 7:035008.
6. Jettanacheawchankit S., Sasithanasate S., Sangvanich P., Banlunara W., Thunyakitpisal P. Acemannan stimulates gingival fibroblast proliferation; expressions of keratinocyte growth factor-1, vascular endothelial growth factor, and type I collagen and wound healing. J Pharmacol Sci 2009, 109:525-531.
7. Jittapiromsak N., Sahawat D., Banlunara W., Sangvanich P., Thunyakitpisal P. Acemannan, an extracted product from Aloe vera, stimulates dental pulp cell proliferation, differentiation, mineralization, and dentin formation. Tissue Eng, A 2010, 16:1997-2006.
8. Clark R.A., Pavlis M. Dysregulation of the mTOR pathway secondary to mutations or a hostile microenvironment contributes to cancer and poor wound healing. J Invest Dermatol 2009, 129:529-531.
9. Squarize C.H., Castilho R.M., Bugge T.H., Gutkind J.S. Accelerated wound healing by mTOR activation in genetically defined mouse models. PLoS ONE 2010, 5:e10643.
10. Xu K.P., Li Y., Ljubimov A.V., Yu F.S. High glucose suppresses epidermal growth factor receptor/phosphatidylinositol 3-kinase/Akt signaling pathway and attenuates corneal epithelial wound healing. Diabetes 2009, 58:1077-1085.
11. Squarize C.H., Castilho R.M., Gutkind J.S. Chemoprevention and treatment of experimental Cowden's disease by mTOR inhibition with rapamycin. Cancer Res 2008, 68:7066-7072.
12. Ma X.M., Blenis J. Molecular mechanisms of mTOR-mediated translational control. Nat Rev Mol Cell Biol 2009, 10:307-318.
13. Hashemolhosseini S., Nagamine Y., Morley S.J., Desrivieres S., Mercep L., Ferrari S. Rapamycin inhibition of the G1 to S transition is mediated by effects on cyclin D1 mRNA and protein stability. J Biol Chem 1998, 273:14424-14429.
14. Sonenberg N., Hinnebusch A.G. Regulation of translation initiation in eukaryotes: mechanisms and biological targets. Cell 2009, 136:731-745.
15. Graff J.R., Zimmer S.G. Translational control and metastatic progression: enhanced activity of the mRNA cap-binding protein eIF-4E selectively enhances translation of metastasis-related mRNAs. Clin Exp Metastasis 2003, 20:265-273.
16. Behm B., Babilas P., Landthaler M., Schreml S. Cytokines, chemokines and growth factors in wound healing. J Eur Acad Dermatol Venereol 2012, 26:812-820.
17. Hay N., Sonenberg N. Upstream and downstream of mTOR. Genes Dev 2004, 18:1926-1945.
18. Parrales A., Lopez E., Lopez-Colome A.M. Thrombin activation of PI3K/PDK1/Akt signaling promotes cyclin D1 upregulation and RPE cell proliferation. Biochim Biophys Acta 2011, 1813:1758-1766.
19. Parrales A., Lopez E., Lee-Rivera I., Lopez-Colome A.M. ERK1/2-dependent activation of mTOR/mTORC1/p70S6K regulates thrombin-induced RPE cell proliferation. Cellular Signal 2013, 25:829-838.
20. Averous J., Fonseca B.D., Proud C.G. Regulation of cyclin D1 expression by mTORC1 signaling requires eukaryotic initiation factor 4E-binding protein 1. Oncogene 2008, 27:1106-1113.
21. Koziczak M., Hynes N.E. Cooperation between fibroblast growth factor receptor-4 and ErbB2 in regulation of cyclin D1 translation. J Biol Chem 2004, 279:50004-50011.
22. Liang J., Slingerland J.M. Multiple roles of the PI3K/PKB (Akt) pathway in cell cycle progression. Cell Cycle 2003, 2:339-345.
23. Lima M.H., Caricilli A.M., de Abreu L.L., Araujo E.P., Pelegrinelli F.F., Thirone A.C., et al. Topical insulin accelerates wound healing in diabetes by enhancing the AKT and ERK pathways: a double-blind placebo-controlled clinical trial. PLoS ONE 2012, 7:e36974.
24. Goren I., Muller E., Schiefelbein D., Gutwein P., Seitz O., Pfeilschifter J., et al. Akt1 controls insulin-driven VEGF biosynthesis from keratinocytes: implications for normal and diabetes-impaired skin repair in mice. J Invest Dermatol 2009, 129:752-764.
25. Lamb R., Lehn S., Rogerson L., Clarke R.B., Landberg G. Cell cycle regulators cyclin D1 and CDK4/6 have estrogen receptor-dependent divergent functions in breast cancer migration and stem cell-like activity. Cell Cycle 2013, 12:2384-2394.
26. Zhong Z., Yeow W.S., Zou C., Wassell R., Wang C., Pestell R.G., et al. Cyclin D1/cyclin-dependent kinase 4 interacts with filamin A and affects the migration and invasion potential of breast cancer cells. Cancer Res 2010, 70:2105-2114.
27. Koh Timothy J., DiPietro Luisa Ann Inflammation and wound healing: the role of the macrophage. Expert Rev Mol Med 2011, 13:e23. 10.1017/S1462399411001943.
28. Ulrich H., Stefan F. Role of lymphocytes in myocardial injury, healing, and remodeling after myocardial infarction. Circ Res 2015, 116:354-367.
29. Weirather J., Hofmann U.D.W., Beyersdorf N., Ramos G.C., Vogel B., Frey A., et al. Foxp3+ CD4+ T cells improve healing after myocardial infarction by modulating monocyte/macrophage differentiation. Circ Res 2014, 115:55-67.
30. Pyzik M., Piccirillo C.A. TGF-1 modulates Foxp3 expression and regulatory activity in distinct CD4T cell subsets. J Leukoc Biol 2007, 82:335-346.
31. Sokol H., Diane M., Benoist Christophe The AKT-mTOR axis regulates de novo diferentiation of CD4+ Foxp3+ cells. JEM 2008, 205:565-574.
32. Hu Z., Kai Y., Caryn C., Geoffrey N., Peter V., Hongbo Ch. mTORC1 couples immune signals and metabolic programming to establish T reg cell function. Nature 2013, 499:485-490.